glp 1/gip medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica How GLP-1 medications are transforming

17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD

[DOI] [PMC free article] [PubMed] [Google Scholar] 285.Food and Drug Administration (FDA)

Retrieved from Lopez, M

Youll also want to make sure your doctor is monitoring you to make sure the GLP-1s dont interact with any of your RA medications, says Lane